about
Beta-thalassemiaTreatment for osteoporosis in people with ß-thalassaemiaHydroxyurea for reducing blood transfusion in non-transfusion dependent beta thalassaemiasTreatment for osteoporosis in people with ß-thalassaemiaEfficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromesβ-thalassemia intermedia: a clinical perspectiveHydroxyurea for reducing blood transfusion in non-transfusion dependent beta thalassaemias.Liver iron content determination by magnetic resonance imaging.Complications and treatment of patients with β-thalassemia in France: results of the National Registry.Thalassaemia is a tropical disease.Frequency of cholelithiasis in patients with Beta-thalassemia intermedia with and without hydroxyurea.Identification and key management of non-transfusion-dependent thalassaemia patients: not a rare but potentially under-recognised conditionEchocardiographic evaluation of thalassemia intermedia patients in Duhok, Iraq.Endocrine and bone complications in β-thalassemia intermedia: current understanding and treatmentComparative study of radiographic and laboratory findings between Beta thalassemia major and Beta thalassemia intermedia patients with and without treatment by hydroxyureaSensitization to minor antigens is a significant barrier in bone marrow transplantation and is prevented by CD154:CD40 blockade.Beta-thalassemia.β-Thalassemia Intermedia: A Bird's-Eye View.Nutritional biomarkers in children and adolescents with Beta-thalassemia-major: An Egyptian center experienceOptimal management of β thalassaemia intermedia.The effect and side effect of hydroxyurea therapy on patients with β-thalassemia: a systematic review to December 2012.Revisiting beta thalassemia intermedia: past, present, and future prospects.National registry of hemoglobinopathies in Spain (REPHem).First report of acute lymphoblastic leukemia in an Egyptian child with β-thalassemia major.Evaluation of the Relationship Between Hb F Levels and Nucleated Red Blood Cells with Morbidity in Non Transfusion-Dependent Thalassemia Patients.Thalassemia Phenotypes and Genotypes in Taiwan: A Retrospective Study Based on Thalassemia Screening of Young Men for Military Conscription.Fermented papaya preparation for β-thalassemia?Adverse effects of hydroxyurea in beta-thalassemia intermedia patients: 10 years' experience.Complications of β-thalassemia intermedia in Iran during 1996-2010 (single-center study).The effect of histone deacetylase inhibitors on AHSP expression.Transfusion in Haemoglobinopathies: Review and recommendations for local blood banks and transfusion services in Oman.
P2860
Q21202886-D9C93C62-A355-4991-8C14-BDBD49AB8FD7Q24186036-EF27A11C-7839-4D80-8EE1-4F09D0CD1470Q24187646-3C60CACA-75D8-4147-B076-6ABC8AB47951Q24200472-86A2F091-6EC0-4EE4-AF63-68EE4B19132BQ26764818-CF7B71D0-485D-4A5A-9119-E9899954BC33Q26828512-0D73DFF8-699C-4D09-BAD4-FBC93D6A05E8Q33436115-8BF54CA4-6D80-4BBA-9CC6-F9C1B03F4E50Q33764777-BB4C4332-EE26-41ED-87F0-8C5E5C85196CQ33829058-CC3AD7C8-9666-4F4D-8CF3-5C106C93E215Q33950343-F23E6065-78C4-4E60-B3B3-2F4F805E1FF1Q34197393-2CA7327D-A3DA-4169-813D-6A61C61C6C31Q34324102-19CEA9FF-DC8A-4D4C-8924-75CD4774616DQ34748686-2EFB614E-AA1E-4063-83BF-992776101A8AQ35193628-C09C26A0-DE4F-4311-B519-1904D92C5856Q35225524-EE5EB9D8-3B15-4C94-B6CA-0727608379E6Q35372567-65E3D723-16A0-49C2-B6D5-EF91C11B063BQ37680651-33E1952D-1C96-4567-A64A-D14AAB2ABFA0Q37718392-6B722AED-14DB-41FB-A358-514C72483136Q37725498-17CDAAFA-09DC-42F8-9C24-A0082E9B9B35Q37830724-E6BAD9F1-37CB-4222-8F7F-52B434FF76E2Q38229328-4CDBE0DE-5F41-4238-A0E4-5CBED02300F7Q38673817-F7F1519C-8CD7-4E41-A88B-094C2F23083EQ38800491-B0C7A6A0-E99E-4F98-9605-9BFBC5B0C6C6Q39455820-D0932FA6-D66D-4FB3-BB38-12CAD61C24E9Q40742219-70D302E6-6827-404A-9C24-61376ECCF390Q41658825-412DB630-A9C0-419C-83A7-8CBB5E593DA8Q42807488-EE294F2E-C041-41D2-8C01-683D2F0E82D1Q43109610-0F6C5468-BAA9-47DB-BD1F-57EB84613201Q45732733-B6772E0E-B6D0-4B8A-9735-080BF3AE0698Q48123934-BEAA005F-C84E-4C2F-B168-2D64030FA169Q55073506-0D08A0E5-FE41-4883-BF37-137CC454BAC0
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Modern treatment of thalassaemia intermedia.
@en
type
label
Modern treatment of thalassaemia intermedia.
@en
prefLabel
Modern treatment of thalassaemia intermedia.
@en
P2860
P1476
Modern treatment of thalassaemia intermedia.
@en
P2093
Caterina Borgna-Pignatti
P2860
P304
P356
10.1111/J.1365-2141.2007.06654.X
P407
P577
2007-06-12T00:00:00Z